Remarkably, the DNaseI activity was significantly lower in BC patients (1.97 μU/μL; 0.93-3.28) than in controls (4.05; 2.32-6.00) (P<0.0001; Figure 1G), as seen in the activity halo (Figure 1H). The gene discussed is DNASE1; the disease is breast cancer.